London, United Kingdom, July 31, 2018
The European Medical Journal has published the latest edition of EMJ Rheumatology, which includes a full review of the European League Against Rheumatism (EULAR) congress, a selection of peer-reviewed papers, interviews with members of our esteemed editorial board, and much more.
During an enthralling 4 days in June, in Amsterdam, Netherlands, EULAR 2018 celebrated the success of the ‘Don’t Delay, Connect Today’ campaign, which was internationally launched at last year’s EULAR congress and aimed to raise awareness of rheumatic conditions to encourage earlier diagnosis for better outcomes. The congress has grown significantly, both in terms of participants and the breadth of research on offer, and as such there is sure to be something to pique interest in the Congress Review found within this eJournal, both for those who were in attendance at the event and simply want to refresh their memory, and for those within the field who were unable to be present and are interested in staying up-to-date with the latest cutting-edge research.
Inside EMJ Rheumatology 5.1, authors of presentations at EULAR summarise the findings and wider implications of their research in the Abstract Review section, whilst our assortment of peer-reviewed articles covers topics ranging from primary Sjögren’s syndrome to dietary components in the treatment of rheumatoid arthritis.
With plenty to offer, EMJ Rheumatology 5.1 is sure to showcase fascinating content that will spark countless hours of intense debate and discussion, no doubt leading to further developments and breakthrough discoveries in the treatment of rheumatological disorders.
If you would like more information about this publication, please call Stacey Rivers at +44 (0) 1245 334450, or email [email protected].
Notes to Editors
About EMJ
Renowned for being the only medical journal to review the biggest European congresses, six weeks after each event is held, the European Medical Journal, is an independent, open-access eJournal dedicated to delivering first-class insights into ground-breaking changes, and advancements in the field.
Spanning sixteen therapeutic areas, including Innovations, Cardiology, Oncology, and more, each journal provides the reader with the latest from the field within our medical congress highlights, abstract reviews, and peer-reviewed articles to name but a few of its wide content selection. Flagship EMJ journals are also published quarterly, bringing an assortment of research and review papers from a variety of topics, alongside unique features and interviews. If you’re interested in receiving quarterly newsletters, and the latest publications straight to your inbox, please do subscribe for free: https://www.emjreviews.com/mailing-list/.
